baber/WOPTO huggingface dataset:
Patent NZ-504754-A (NZ)
Title: Carrier and spacer assembly for vertical blinds with spacers between carriers contacting front and rear carriers at laterally differing locations to lessen effect of yawing during blind carrier and spacer movement
Inventor: WELFONDER KONRAD
IPC: E06B9/36
Filed: 2000-05-24
Abstract: Carriers 11, 11', 11'', _, typically for a vertical venetian blind assembly, are interconnected by spacers 13', 13", _, which are fixed at one end and slide relative to adjacent carriers.  In order to reduce the effect of yawing of carriers (due to laterally offset longitudinal loading) grooves in the carriers are angled laterally.
Patent NZ-504794-A (NZ)
Title: Ventilation diffuser
Inventor: SHEPHERD MARK LESLIE
IPC: F24F13/062
Filed: 2000-05-26
Abstract: A ventilation diffuser includes a housing 2 that fits into a ceiling and is attached to a ventilation duct.  The housing has an opening 14 into which air deflector 3 is fitted.  A barrier plate 4 can be fitted into the gap between the housing and deflector so as to control the direction of airflow from the diffuser.  The barrier plate blocks airflow at selected places around the diffuser outlet and the position of the barrier plate can be adjusted to block different sections of the annular gap between the housing and deflector with the housing installed and the diffuser engaged with the housing.
Patent NZ-508716-A (NZ)
Title: Concrete comprising organic fibres dispersed in a cement matrix, concrete cement matrix and premixes
Inventor: CHEYREZY MARCEL
IPC: C04B14/20
Filed: 1999-05-12
Abstract: Concrete comprises organic fibres dispersed in a hardened cement matrix.  Concrete comprising organic fibres dispersed in a hardened cement matrix is obtained by mixing with water composition comprising fibres and: (a) cement; (b) granular components with maximum size, D, of no more than 2 mm, preferably no more than 1 mm; (c) fine components from ash with size no greater than 20 microns preferably no greater than 1 microns; and (d) at least one dispersing agent; the composition meeting the following conditions: (e) wt. % water with respect to total weight of (a) and (c) = 8-25; (f) organic fibres have individual length, l , of at least 2 mm and ratio l\/ phi ( phi = diameter) at least = 20; (g) ratio, R, of mean length of fibres to D at least = 5; and (h) quantity of fibres is such that their volume represents no more than 8% total volume of concrete.  An independent claim is also included for a cement matrix for making the concrete.
Patent NZ-511015-A (NZ)
Title: 1, 6-Dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives useful for treating impotence
Inventor: KIM SOONHOE
IPC: A61P15/10
Filed: 1999-11-10
Abstract: A    pyrazole-pyrimidinone    derivative    or     a pharmaceutically  acceptable salt thereof  has  the  formula (I) wherein: R1 is an alkyl group; R2  and R3 are independently an optionally substituted alkyl group and R4  is  an  optionally substituted alkyl  group,  cycloalkyl group, benzene, pyridine, or a pyrrole. The compounds are useful for treating impotence.
Patent NZ-515626-A (NZ)
Title: Methods of making and using N-desmethylzopiclone
Inventor: JERUSSI THOMAS P
IPC: A61P25/32
Filed: 2000-05-11
Abstract: Use of N-desmethylzopiclone for treating anxiety, convulsive attacks and other disorders. Also disclosed is the preparation of racemic N-desmethylzopiclone.
Patent NZ-516597-A (NZ)
Title: Aqueous polymer dispersion
Inventor: CAREY MICHELLE JOCELYN
IPC: C08F265/06
Filed: 2000-07-13
Abstract: A process for preparing an aqueous dispersion of water insoluble polymer particles comprising: a) preparing by polymerization an aqueous dispersion of water insoluble particles of a heteropolymer including monomeric units of a reactive amphiphile having a cloud point and monomeric units of a hydrophilic monomer. The polymerisation is conducted in the presence of a stabilizing agent, reactive amphiphile and at a temperature above the cloud point of said amphiphile, b) cooling the aqueous dispersion to a temperature below the cloud point of the reactive amphiphile such that the viscosity of the aqueous dispersion increases.
Patent NZ-524410-A (NZ)
Title: A fishing accessory that can be a float or a sinker
Inventor: RYDER LANCE LEWIS
IPC: A01K93/00
Filed: 2003-02-24
Abstract: A fishing line accessory that can function as both a float and a sinker, comprising a body that has a hollow compartment, an outlet communicating with the hollow compartment and the exterior of the body, a closure which closes the outlet and able to also adopt an open position.  The compartment and outlet allow a solid or liquid to be added or removed to adjust the buoyancy of the accessory and thus convert it to the desired floater or sinker position.  The compartment has a larger volume adjacent to the outlet and a smaller volume spaced from the outlet.
Patent NZ-533376-A (NZ)
Title: Use of micro-organisms for a directed delivery of substances to specific parts of the gut
Inventor: CORTHESY-THEULAZ IRENE
IPC: A61P43/00
Filed: 2002-11-25
Abstract: A lactic acid bacteria capable of lysing and releasing substances beneficial to the host can be used in the manufacture of a composition for supporting the well being of individuals and/or for the treatment and/or prophylaxis of disease.
Patent NZ-537286-A (NZ)
Title: Vibrational apparatus
Inventor: PFAHLERT ROGER
Filed: 2004-12-14
Abstract: Vibrational apparatus capable of providing a vibrational output, the apparatus comprising or including an assembly having a shuttle capable of shuttling between complementary structures, at least one of which complementary structures provides the vibrational output, the arrangement being characterised in that there is a mechanical drive to rotate the shuttle and there are magnetic interactions between the rotating shuttle and the complementary structures such that interactions with each complementary structure, and the phasing of the complementary structures relative to the shuttle, results in the shuttling movement of the shuttle.
Patent NZ-539052-A (NZ)
Title: Locking bars for multi-drawer cabinets being inter-connectable end to end
Inventor: GATLAND GRANT
Filed: 2005-03-22
Abstract: A locking bar is disclosed of or for a multi-drawer cabinet that is of elongate form and having ends of two types of complementary form so that opposite ends of bars can be interconnected in daisy chain fashion with their longitudinal axes in alignment.
Patent NZ-541690-A (NZ)
Title: Pneumatically actuated valve for internal combustion engines
Inventor: KLEIN JEFFREY F
IPC: F01L9/16
Filed: 2004-01-30
Abstract: A pneumatically actuated valve assembly for use as intake and/or exhaust valves on two- or four-stroke internal combustion engines. The assembly includes a valve (100), valve housing (200), and compressed gas distribution and timing mechanisms (Figures 5-8). The valve (100) is comprised of a short light weight hollow cylindrical body with a capped lower end and an opened upper end. The valve is further defined by a plurality of ports (104) adjacent to the lower end and a collar (198) encircling the body adjacent the upper end. The valve housing (200) is hollow and tubular having a larger diameter upper section and a smaller diameter lower section in which the valve (100) slides up to close and down to open. The housing (200) further includes hollow channels which direct compressed gas, managed by the distribution and timing mechanism, alternately towards the areas above and below the valve collar at regular intervals to open and close the valve, respectively.
Patent NZ-545736-A (NZ)
Title: Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
Inventor: LIU ZIPING
IPC: C07D405/06
Filed: 2004-09-24
Abstract: Disclosed is a compound of formula I or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification. The compounds are useful in the treatment of pain, anxiety disorders, cancer, multiple sclerosis, Parkinson's disease, Huntington's chorea, Alzheimer's disease, gastrointestinal disorders and cardiovascular disorders.
Patent NZ-548166-A (NZ)
Title: Peptide inhibiting angiontensin converting enzyme
Inventor: TONOUCHI HIDEKAZU
IPC: A61K38/06
Filed: 2004-12-01
Abstract: Provided is a peptide, which is an inhibitor of angiotensin-converting enzyme. Further provided are variants of the peptide and use of the peptide for the manufacture of medicaments for hypertension and other cardiac diseases.
Patent NZ-549831-A (NZ)
Title: Combination of docetaxel and a nitrophenyl phosphate derivative for the treatment of cancer
Inventor: PATTERSON ADAM VORN
Filed: 2006-09-11
Abstract: The disclosure relates to a combination therapy for cancer treatment. Particularly disclosed is the use of a compound of formula (I), wherein: X represents at any available ring position -CONH-, -SO2NH-, -O-, -CH2-, -NHCO- or -NHSO2-; R represents a lower C1-6 alkyl optionally substituted with one or more groups including hydroxyl, amino and N-oxides therefrom or dialkylamino and N-oxides therefrom; Y represents at any available ring position -N-aziridinyl, -N(CH2CH2W)2 or -N(CH2CHMeW)2, where each W is independently selected from halogen or -OSO2Me; Z represents at any available ring position -NO2, -halogen, -CN, -CF3 or -SO2Me; or a pharmaceutically acceptable salt or derivative thereof, in the preparation of a medicament for administration before, after or simultaneously with an effective amount of docetaxel for the treatment of cancer in a warm-blooded animal such as a human. Also disclosed is a pharmaceutical composition which comprises a compound of formula (I) or a pharmaceutically acceptable salt or derivative thereof, and docetaxel, in association with a pharmaceutically acceptable excipient or carrier.
Patent NZ-553693-A (NZ)
Title: A bacterial ATP synthase binding domain
Inventor: ANDRIES KOENRAAD JOZEF LODEWIJK MARCEL
IPC: C12N15/52
Filed: 2005-09-28
Abstract: Provided is an isolated and purified polypeptide comprising a binding site in the F0 part of an ATPase defined by the structural coordinates of amino acids 14-34 or 54-69 of an atpE protein as in any of table 6 or homologous structure coordinates comprising a root mean square deviation of non-hydrogen atoms of less than about 1.5Å. Further provided are methods of selecting atpE interacting proteins using the polypeptides and methods of producing the mutant atpE proteins.
Patent NZ-560737-A (NZ)
Title: Analgesic and anti-inflammatory composition
Inventor: EDWARD JEFFREY D
IPC: A61K35/16
Filed: 2006-02-10
Abstract: Disclosed is a composition comprising an effective amount of an analgesically and/or anti-inflammatory active fraction separated from a mixture of plasma and/or serum and at least one metal, selected from the group consisting of nickel, sodium, copper, zinc, cobalt, iron, magnesium, manganese, potassium, silver and mercury, or a metal ion or metal salt thereof, wherein said mixture has been denatured. A method of producing an analgesic and/or anti-inflammatory composition is also disclosed, which comprises: (a) heat denaturing a mixture of plasma and/or serum and at least one metal, selected from the group consisting of nickel, sodium, copper, zinc, cobalt, iron, magnesium, manganese, potassium, silver and mercury, or a metal ion or metal salt thereof; (b) incubating said mixture in the presence of a protease to produce a digested mixture; (c) heating said digested mixture; and (d) separating an analgesically and/or anti-inflammatory active fraction from said denatured mixture.
Patent NZ-564374-A (NZ)
Title: Indane derivatives as modulators of ion channels
Inventor: NEUBERT TIMOTHY
IPC: A61K31/426
Filed: 2006-06-09
Abstract: Disclosed are indane derivatives as represented by the general formula I which are useful compounds for inhibiting ion channels (such as of NaV1.1, NaV1.2, NaV1.3, NaV1.4, NaV1.5, NaV1.6, NaV1.7, NaV1.8, NaV1.9, or CaV2.2); wherein: ring Z is a 1,3-thiazole moiety as defined herein which may be substituted with RZ; X is a bond, O, NR2, or C(R2)--2; Q is a bond or a straight or branched alkylidine chain, wherein up to two nonadjacent methylene units of Q are optionally and independently replaced as defined herein; RQ is a 3-8-membered saturated, partially unsaturated, or fully unsaturated monocyclic ring having 0-3 heteroatoms independently selected from O, S, N, or NH, or an 8-12 membered saturated, partially unsaturated, or fully unsaturated bicyclic ring system having 0-5 heteroatoms independently selected from O, S, N, or NH; wherein RQ is optionally substituted with up to 5 substituents selected from R1, R2, or R4; and wherein the remaining substituents are as defined herein. Also disclosed is the use of a compound as defined above in the manufacture of a medicament for treating or lessening the severity of a disease, disorder, or condition selected from acute, chronic, neuropathic, or inflammatory pain, arthritis, migraine, cluster headaches, trigeminal neuralgia, herpetic neuralgia, general neuralgias, epilepsy or epileptic conditions, neurodegenerative disorders, psychiatric disorders such as anxiety and depression, myotonia, arrhythmia, movement disorders, neuroendocrine disorders, ataxia, multiple sclerosis, irritable bowel syndrome, incontinence, visceral pain, osteoarthritis pain, postherpetic neuralgia, diabetic neuropathy, radicular pain, sciatica, back pain, head or neck pain, severe or intractable pain, nociceptive pain, breakthrough pain, postsurgical pain, stroke, bipolar disorders, or cancer pain.
Patent NZ-565933-A (NZ)
Title: Adjustable mount for controller of power driven wheelchair
Inventor: JAENKE BRUCE A
IPC: A61G5/10
Filed: 2006-08-31
Abstract: An apparatus 102 for mounting a device 152 to a wheelchair, comprises an aperture 126 for receiving a projection 162 extending from the device 152, where the size of the aperture 126 can be changed using a bolt 110 and nut 108, and where the opening 126 can receive the projection 162 in one of a number of different discrete orientations. The device 152 can thus be mounted in a number of different positions.
Patent NZ-568598-A (NZ)
Title: Endo-tracheal tube securement system
Inventor: BIERMAN STEVEN F
IPC: A61M16/04
Filed: 2006-12-15
Abstract: Disclosed is an endo-tracheal tube securement system. The system includes a head contact member, two upper attachment members, and two lower attachment members. Each attachment member extends from the head contact member. The two lower attachment members are configured to lie below a line connecting the lips and ear of a patient when the securement system is installed upon the patient. The system includes a retainer with a posterior facing surface, a channel and a number of securing locations disposed on each side of the channel. The channel is configured to receive a portion of the endo-tracheal tube so as to inhibit movement of the endotracheal tube relative to the retainer. The posterior facing surface is configured to inhibit movement of the retainer into the patient's mouth. The attachment members are configured to attach to the securing locations on the retainer so as to secure the endo-tracheal tube to the head contact member. The system further includes two crossover attachment members, each attaching one of the two upper attachment members to one of the two lower attachment members so as to inhibit the two lower attachment members from migrating in a downward direction and over the mandible or jaw bone of the patient.
Patent NZ-574367-A (NZ)
Title: Mixture to add odour to an odourless combustible gas
Inventor: CHARLES PATRICK
IPC: C10L3/00
Filed: 2007-06-25
Abstract: Disclosed is an odorizing composition comprising: - at least one alkyl acrylate;- at least one compound of formula (II) in which: - R1 and R2, which may be identical or different, each represent a tertiary or secondary hydrocarbon-based radical; or- R1 and R2, taken with the nitrogen atom to which they are attached, form a cyclic hydrocarbon-based radical e.g. TEMPO.
Patent NZ-574807-A (NZ)
Title: Methods and means for treating dna repeat instability associated genetic disorders
Inventor: PLATENBURG GERARD JOHANNES
IPC: C12N15/113
Filed: 2007-08-10
Abstract: Disclosed is the use of a single stranded oligonucleotide consisting of a sequence that is complementary only to a repetitive element in a gene transcript for the manufacture of a medicament for the treatment or prevention of a human cis-element repeat instability associated genetic disorder. Repetitive element in a gene transcript is selected from the group consisting of (CAG)n, (GCG)n, (CUG)n, (CGG)n, (CCG)n, (GAA)n, (CCUG)n, and (ATTCT)n.
Patent NZ-592329-A (NZ)
Title: Process for enhancing electrostatic separation in the beneficiation of ores
Inventor: WANG BING
IPC: B03C7/00
Filed: 2009-10-21
Abstract: 592329 Disclosed herein is a process for beneficiating a mineral substrate by electrostatic separation, said mineral substrate comprising a conducting mineral component and/or a non-conducting mineral component. The process comprises forming a slurry of the mineral components and an electrostatic modification reagent, drying said slurry to form a substantially dry mixture, and applying an electric field to the mixture to effect separation, wherein the electrostatic modification reagent is chosen from an organic compound selected from the group consisting of quaternary amines, imidazoline compounds, dithiocarbamate compounds, pyridine compounds, pyrrolidine compounds, conducting polymers, polyethyleneimines, benzenesulfonic acid compounds and benzenesulfonate compounds. In one embodiment the electrostatic modification reagent further comprises a plurality of particles a plurality of particles having an average specific resistivity that is greater than or equal to the specific resistivity of the non-conducting mineral component when the non-conducting mineral component is electrostatically modified, and/or a plurality of particles having an average specific resistivity that is less than or equal to the specific resistivity of the conducting mineral component when the conducting mineral component is electrostatically modified.
Patent NZ-593402-A (NZ)
Title: Processing of biomass
Inventor: BROOKS STEPHEN
IPC: D21C3/00
Filed: 2009-11-23
Abstract: 593402 Disclosed is method of processing biomass which comprises the digestion of biomass material in an aqueous solvent system comprising water, a water miscible solvent and a water immiscible solvent and including an organic acid; subjecting it to ultrasonic waves and separating the biomass into its constituents of lignin, hemicellulose and cellulose. Also disclosed is a method for hydrolysis of hemicellulose, an apparatus and a mobile reactor.
Patent NZ-595458-A (NZ)
Title: Organic compounds and their use for treating hcv
Inventor: SIMIC OLIVER
IPC: A61K38/08
Filed: 2010-04-09
Abstract: Abstract - 595458 Disclosed herein is a compound or a pharmaceutically acceptable salt thereof selected from the given formulaes, processes for their preparation, pharmaceutical compositions comprising said compounds and uses thereof in the treatment of HCV-associated disorders, such as HCV infection, liver cirrhosis, chronic liver disease, hepatocellular carcinoma, cryoglobulinaemia, non-Hodgkin's lymphoma, liver fibrosis and a suppressed innate intracellular immune response. Particularly preferred compounds include: (5R,8S)-7-[(2S)-2-{ [(2S)-2-cyclohexyl-2-({ [(2S)-1-isopropylpiperidin-2-yl]carbonyl} amino)acetyl]amino} -3,3-dimethylbutanoyl]-N-{ (1 R,2R)-2-ethyl-1-[(pyrrolidin-1-ylsulfonyl)carbamoyl]cyclopropyl} -10,10-dimethyl-7-azadispiro[3.0.4.1]decane-8-carboxamide; (5R,8S)-7-[(2S)-2-{ [(2S)-2-cyclohexyl-2-({ [(2S)-1-isopropylpiperidin-2-yl} carbonyl} amino)acetyl]amino} -3,3-dimethylbutanoyl]-10,10-dimethyl-N-{ (1R,2S)-1-[(pyrrolidin-1-ylsulfonyl)carbamoyl]-2-vinylcyclopropyl} -7-azadispiro[3.0.4.1]decane-8-carboxamide.
Patent NZ-597925-A (NZ)
Title: Wireless detectable tamper evident seal
Inventor: ELCOMBE JONATHAN HUGH
IPC: B65D5/43
Filed: 2010-07-26
Abstract: 597925 Disclosed is a wirelessly detectable tamper-evident seal. The tamper-evident seal includes a receptacle part (see '10', figure 1a) and a frangible part (see '50', figure 1a). The receptacle part includes a first receptacle (see '10a', figure 1a) and a second receptacle (10b-d) which is attachable to a container (77) to seal a closure of the container. The frangible part includes a first portion (see '51', figure 3a) and a second portion (see '52', figure 3a) frangibly connected to each other and a transponder (see '54', figure 3a). The first receptacle of the receptacle part is adapted to receive the first portion of the frangible part and the second receptacle of the receptacle part is adapted to receive the second portion of the frangible part. The second portion of the frangible part is able to be trapped against movement in the reverse direction in the second receptacle to effect a tamper evident seal between the first and second receptacles. The transponder includes at least two circuit interruption locations (see '94a' & '94b', figure 4) that must be connected to activate the transponder. The transponder is activatable by inserting the second portion in the second receptacle to connect both or all circuit interruption locations. A method for sealing a container with a wirelessly detectable tamper evident seal is also provided.
Patent NZ-598258-A (NZ)
Title: System and method for pressurizing a plastic container
Inventor: DARR RICHARD C
IPC: B65B61/24
Filed: 2010-02-09
Abstract: 598258 Disclosed is a system (10) for manufacturing a pressurised filled plastic container (50), such as a thin-walled plastic bottle. The system includes an actuator (20) and a base unit (30). The actuator includes a body portion and a holding/securing member (40) configured to hold or secure a top portion of a container such that a base portion of the container is not held. The base unit includes a heating surface (32) and is configured to receive a base portion of the container. The heating surface is configured to convey energy or heat to a portion of the base portion of the container. The actuator is configured to apply a force or pressure on a container such that a portion of the base portion of the container directly contacts the base unit, thereby deforming the base portion of the container inwards and pressurising the contents of the container (see figures 5A-5C). Methods of providing a filled plastic container are also disclosed.
Patent NZ-599137-A (NZ)
Title: Peptidic glp-2 agonists
Inventor: ALAGARSAMY SUDARKODI
IPC: A61K38/00
Filed: 2010-10-21
Abstract: Disclosed is a novel GLP-2 analogue as defined in the specification. The disclosed compound has improved pharmacokinetic properties as described in the specification and is used in the treatment of a myriad of diseases.
Patent NZ-599563-A (NZ)
Title: Patient interface
Inventor: LUBKE STEVEN JOHN
IPC: A61M16/06
Filed: 2008-07-28
Abstract: A patient interface for delivering breathable gas to a patient, the patient interface comprising: a nasal prong assembly including a pair of nasal prongs structured to sealingly communicate with nasal passages of a patient’s nose in use; and headgear to maintain the nasal prong assembly in a desired position on the patient’s face. The headgear includes first and second side straps (5055) and respective rigidizers (5055(3)) provided to respective side straps. Each rigidizer includes a first end portion (5055(1)) that provides a connector structured to engage a respective end of the nasal prong assembly and a second end portion (5055(2)) in the form of a protrusion that curves inwardly of the connector and forms a cheek support. The cheek support is adapted to follow the contour of the patient’s cheek and guide a respective end portion of the side strap into engagement with the patient’s cheek to provide a stable cheek support.